B. Chesson

发表

Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases

Tomas Kron, Rodney J. Hicks, Farshad Foroudi, 2014, Journal of medical imaging and radiation oncology.

VIDENCE OF A NONLINEAR HUMAN MAGNETIC SENSE

B. Chesson, C. Frilot, 2006 .

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

S. Vinod, N. Hardcastle, G. Sasso, 2016, BMC Cancer.

Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases

T. Kron, S. Siva, D. Ball, 2015, Acta oncologica.

Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.

N. Hardcastle, T. Kron, D. Ball, 2018, The British journal of radiology.

RADIATION ONCOLOGY—ORIGINAL ARTICLE Analysis of the impact of chest wall constraints on eligibility for a randomized trial of stereotactic body radiotherapy of peripheral stage I non-small cell lung cancer

S. Siva, D. Ball, B. Chesson, 2012 .

Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions

N. Hardcastle, T. Kron, S. Siva, 2014, Australasian Physical & Engineering Sciences in Medicine.

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Tomas Kron, Andrew Wirth, Benjamin Solomon, 2019, The Lancet. Oncology.

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.

S. Vinod, N. Hardcastle, G. Sasso, 2021, JAMA oncology.

Novel 3D conformal technique for treatment of choroidal melanoma with external beam photon radiotherapy

Jim Cramb, Claire Phillips, Brent Chesson, 2013, Journal of medical imaging and radiation oncology.

Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma

M. MacManus, B. Chesson, T. Fua, 2013, Leukemia & lymphoma.

Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial

N. Lawrentschuk, D. Murphy, T. Kron, 2017, BJU international.

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy

D. Murphy, N. Hardcastle, T. Kron, 2019, Radiation Oncology.

MA 13.07 A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL)

S. Vinod, T. Kron, J. Ruben, 2017 .

Implementation of a lung radiosurgery program: Technical considerations and quality assurance in an Australian institution

T. Kron, S. Siva, D. Ball, 2012, Journal of medical imaging and radiation oncology.

Friday 24 July 2015

Heather K. Neilson, Stuart A. Sievers, W. Starbuck, 2015, Journal of Medical Radiation Sciences.

Engineering & Physical Sciences in Medicine Conference 2013 Pan Pacific Hotel, Perth, Australia, 3–7 November 2013 Oral presentation abstracts

T. Kron, Daniel P Steinfort, J. Ruben, 2014, Australasian Physical & Engineering Sciences in Medicine.

Planning for a pandemic: Mitigating risk to radiation therapy service delivery in the COVID‐19 era

B. Chesson, N. Anderson, D. Phillips, 2020, Journal of medical radiation sciences.

A Multidisciplinary Evaluation of a Web-based eLearning Training Programme for SAFRON II (TROG 13.01): a Multicentre Randomised Study of Stereotactic Radiotherapy for Lung Metastases.

N. Hardcastle, T. Kron, S. Siva, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

The effect of irregular breathing patterns on internal target volumes in four-dimensional CT and cone-beam CT images in the context of stereotactic lung radiotherapy.

T Kron, P Roxby, L Dunn, 2013, Medical physics.

Analysis of the impact of chest wall constraints on eligibility for a randomized trial of stereotactic body radiotherapy of peripheral stage I non‐small cell lung cancer

S. Siva, D. Ball, S. Gill, 2012, Journal of medical imaging and radiation oncology.

Single Fraction Stereotactic Ablative Body Radiotherapy for Oligometastasis: Outcomes from 132 Consecutive Patients.

T. Kron, S. Siva, D. Ball, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiochromic film for individual patient QA in extracranial stereotactic lung radiotherapy

L. Dunn, T. Kron, D. Ball, 2011 .

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

V. Khoo, N. Lawrentschuk, N. Hardcastle, 2018, BMC Cancer.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

S. Vinod, J. Ruben, L. Irving, 2019, The Lancet. Oncology.